Delivery Order SPE2DB24D9238-SPE2DB24FDQMR

Award Date 8/23/24
Potential Completion Date 9/16/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $3,094.80 and an ultimate completion date of February 3, 2025. DMS Pharmaceutical Group Inc. also holds a significant single-award Indefinite...
This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGEML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $4,642.20 and an ultimate completion date of October 10, 2024. It is part of a larger...
The U.S. government's Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the purchase of Xolair 150 mg/mL auto-injectors, with a ceiling value of $20,546.64. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of XOLAIR 150 MG/ML AUTOINJECTORML, with a ceiling value of $1,712.22 and a term ending on February 24, 2025. The contract is a firm fixed-price delivery order and is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to...
This federal contract award is for the delivery of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at up to $3,868.50, is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with...
This federal contract award is for the delivery of XOLAIR 75 MG/0.5 ML AUTOINJECT 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $3,405.36, is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
This federal contract award is for the delivery of Xolair 300 mg/2 ml autoinjector medication to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $46,230.21, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, issued under DMS Pharmaceutical Group's larger indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,642.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This contract is for the supply of XOLAIR 150 MG/ML SYRINGE, a biologic medication, to support the recurring medical needs of military health facilities. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to...
This federal contract award is for the delivery of XOLAIR 150 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,547.40, was awarded to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract, contract...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XOLAIR 150 mg/mL syringes. The contract has a ceiling value of $3,094.80 and a period of performance through July 29, 2024. This contract was issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which supports the recurring pharmaceutical supply...
  • SPE2DB24D9238
    Indefinite Delivery Contract
  • SPE2DB24D9238-SPE2DB24FDQMR
    Delivery Order

The federal contract award is for the delivery of XOLAIR 150 MG/ML AUTOINJECTORML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois.

The contract is a firm fixed-price delivery order with a ceiling value of $1,712.22 and a completion date of September 16, 2024. It is not designated as a set-aside contract. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities.

Generated 11/22/24, 9:08 AM